Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept

Non-response to intravitreal ranibizumab represents a frequent problem in pachychoroid neovasculopathy (PNV). To investigate the effectivity of switching to aflibercept, the database of the Ludwig Maximilians University, Munich, was screened for patients fulfilling the following inclusion criteria:...

Descripción completa

Detalles Bibliográficos
Autores principales: Schworm, Benedikt, Luft, Nikolaus, Keidel, Leonie F., Herold, Tina R., Wolf, Armin, Priglinger, Siegfried G., Siedlecki, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242401/
https://www.ncbi.nlm.nih.gov/pubmed/32439930
http://dx.doi.org/10.1038/s41598-020-65370-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242401/
https://www.ncbi.nlm.nih.gov/pubmed/32439930
http://dx.doi.org/10.1038/s41598-020-65370-w

Ejemplares similares